Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Norovirus Prevalence and Fecal Microbiome Characterization Through Integrated Metagenomic and Metatranscriptomic Analyses in Patients With a Travel History

NCT07866469 is registered in ClinicalTrials.gov with IRCCS Sacro Cuore Don Calabria di Negrar as lead sponsor.

NCT NCT07866469
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07866469 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Norovirus Prevalence and Fecal Microbiome Characterization Through Integrated Metagenomic and Metatranscriptomic Analyses in Patients With a Travel History
Lead sponsor
IRCCS Sacro Cuore Don Calabria di Negrar
Phase
Not applicable
Overall status
Active, not recruiting
Start date
July 28, 2026
Completion date
July 28, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metagenomic next generation sequencing, microbiome, norovirus infection